Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Samyukta Mullangi on the EOM: MIPS Disproportionately Penalizes Oncologists; ePROs Need Refining
June 3rd 2023"It's really important that oncologists are on level footing along with the rest of their medical peers," said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.
Read More
US Government Spent Far More on Costly HIV PrEP Development Than Previously Thought
June 2nd 2023According to new estimates, the US government spent between $143 million and $314 million in 2022 inflation-adjusted dollars funding the development of tenofovir disoproxil fumarate-emtricitabine. The previous estimate was around $50 million.
Read More
Dr Amal Agarwal: Value-based Contracts Can Help Align Incentives in Dialysis
June 2nd 2023Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.
Read More
Dr Rainelle Gaddy: Reaching Health Equity Is a Marathon, Not a Sprint
May 22nd 2023At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, the strategy advancement lead at Humana talked more about Humana’s health equity strategy and areas that pharmacy benefit managers (PBMs) and health plans can influence.
Read More
Telehealth Has Many Benefits in GI Care, Says Oshi Health's Sam Holliday
May 20th 2023Telehealth provides more flexibility for patients with gastrointestinal issues to better fit their care into their lives and around symptoms they may be experiencing, said Sam Holliday, co-founder and CEO of Oshi Health.
Read More
Dr David Maahs Highlights Advances in Pediatric T1D Technology
May 17th 2023David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital, highlights key points from his review on pediatric diabetes technology and therapy.
Read More
Patient Joins PQA23 Panel on IRA’s Potential Impact on Medication Access, Affordability
May 13th 2023At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).
Read More
IQVIA’s Luke Greenwalt on Increasing Payer Pressures: We Can Change the Path We’re On
May 11th 2023“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.
Read More
Youth Diabetes Risk Perception Not Associated With Engagement in Risk-Reducing Behaviors
May 5th 2023Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.
Read More
Julie Reed Previews Biosimilar Session at Asembia 2023
April 25th 2023At Asembia 2023, there will be a call to action for participants to adjust their current business models and advocate for access to biosimilars with lower list costs, explained Julie Reed, executive director of the Biosimilars Forum.
Read More
T1D Plus Psychiatric Disorders May Influence Educational Outcomes
April 20th 2023Although children with type 1 diabetes (T1D) are slightly more likely to experience long-term educational underachievement than their peers without T1D, those who also have a psychiatric disorder have significantly lower odds of achieving educational milestones.
Read More
People With HIV at Much Higher Risk of Depression, Suicide
April 19th 2023In the first 2 years after receiving an HIV diagnosis, people with HIV were about 3 times more likely to develop depression, use antidepressants, and undergo electroconvulsive therapy—and 10 times more likely to commit suicide—compared with people without HIV.
Read More